Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Hepion Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Hepion Pharmaceuticals Inc market cap is $906,400.00.
What is the 52-week high for Hepion Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Hepion Pharmaceuticals Inc 52 week high is $44.50 as of September 08, 2025.
What is the 52-week low for Hepion Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Hepion Pharmaceuticals Inc 52 week low is $0.033 as of September 08, 2025.
What is Hepion Pharmaceuticals Inc stock price today?
Hepion Pharmaceuticals Inc stock price today is $0.0688.
What was Hepion Pharmaceuticals Inc stock price yesterday?
Hepion Pharmaceuticals Inc stock price yesterday was $0.078.
What is the PE ratio of Hepion Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Hepion Pharmaceuticals Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Hepion Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Hepion Pharmaceuticals Inc P/B ratio is 0.4312.
What is the 50-day moving average of Hepion Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Hepion Pharmaceuticals Inc 50-day moving average is $0.0589.